UBS Keeps Neutral Rating on Stem (STEM)
UBS Coverage and Price Forecast: UBS has maintained a Neutral recommendation for Stem (NYSE:STEM) as of October 31, 2025, with an average one-year price target of $14.96/share, indicating an 11.69% downside from its latest closing price of $16.94/share.
Projected Revenue and EPS: Stem's projected annual revenue is expected to reach $1,203 million, reflecting a significant increase of 629.32%, while the projected annual non-GAAP EPS is -0.17.
Fund Sentiment and Ownership: There has been a notable increase in institutional interest in Stem, with 113 funds reporting positions, a 653.33% increase in ownership over the last quarter, and total shares owned by institutions rising by 39,583.27% to 1,724K shares.
Shareholder Holdings: Key shareholders include Vanguard Total Stock Market Index Fund (2.90% ownership), Vanguard Extended Market Index Fund (1.48%), Bank of America (1.27%), Susquehanna International Group (1.20%), and Geode Capital Management (1.02%).
Trade with 70% Backtested Accuracy
Analyst Views on STEM
About STEM
About the author
Stem Scheduled to Announce Q4 Earnings on March 4
- Earnings Announcement Date: Stem is set to release its Q4 earnings report on March 4 after market close, with market participants keenly awaiting the results, which could impact stock performance.
- Earnings Expectations: Analysts have a consensus EPS estimate of -$1.96, indicating ongoing challenges in profitability that may affect investor confidence and stock valuation.
- Revenue Forecast: The consensus revenue estimate stands at $39.39 million, and any deviation from this figure could lead to stock price volatility, with lower revenues potentially dampening market sentiment.
- Historical Performance Insight: Historical earnings data for Stem will provide investors with critical insights into the company's financial health and market performance, aiding in future investment decisions.
Stem (STEM) Q4 2025 Earnings Call Transcript
Stempress Reports Q4 2025 Financial Results with Strong Revenue Growth
- Significant Revenue Growth: Stempress reported Q4 2025 revenue of $47.2 million, exceeding expectations by $7.81 million, with software, services, and edge hardware revenue reaching $46.5 million, reflecting a robust 62% year-over-year increase that underscores the company's strong market performance and growth potential.
- Improved Profit Margins: GAAP gross profit surged to $23.2 million from a loss of $2.5 million year-over-year, with GAAP gross margin rising to 49%, while non-GAAP gross margin increased from 36% to 45%, indicating significant advancements in cost control and profitability.
- Reduced Net Loss: The company reported a net loss of $16.0 million in Q4 2025, a substantial decrease from $51.1 million in the same quarter last year, reflecting positive changes in operational efficiency and financial health.
- Stable Annual Contract Revenue: The Contracted Annual Recurring Revenue (CARR) for FY25 stood at $67.2 million, down 4% from Q3 but up 4% year-over-year, demonstrating the company's ongoing commitment to maintaining long-term customer relationships and revenue stability.
Stem (STEM) Price Target Raised by 30.68% to $19.55
Price Target Update: The average one-year price target for Stem (NYSE:STEM) has been revised to $19.55 per share, reflecting a 30.68% increase from the previous estimate of $14.96, with current targets ranging from $17.17 to $24.15.
Fund Sentiment: There are 120 funds reporting positions in Stem, marking a 55.84% increase in ownership over the last quarter, with total shares owned by institutions rising by 32.64% to 2,087K shares.
Bullish Outlook: The put/call ratio for Stem is at 0.17, indicating a bullish sentiment among investors.
Shareholder Activity: Notable increases in share ownership have been reported by firms such as Marshall Wace, Bank of America, and Two Sigma Investments, with significant percentage increases in their portfolio allocations to Stem over the last quarter.
UBS Keeps Neutral Rating on Stem (STEM)
UBS Coverage and Price Forecast: UBS has maintained a Neutral recommendation for Stem (NYSE:STEM) as of October 31, 2025, with an average one-year price target of $14.96/share, indicating an 11.69% downside from its latest closing price of $16.94/share.
Projected Revenue and EPS: Stem's projected annual revenue is expected to reach $1,203 million, reflecting a significant increase of 629.32%, while the projected annual non-GAAP EPS is -0.17.
Fund Sentiment and Ownership: There has been a notable increase in institutional interest in Stem, with 113 funds reporting positions, a 653.33% increase in ownership over the last quarter, and total shares owned by institutions rising by 39,583.27% to 1,724K shares.
Shareholder Holdings: Key shareholders include Vanguard Total Stock Market Index Fund (2.90% ownership), Vanguard Extended Market Index Fund (1.48%), Bank of America (1.27%), Susquehanna International Group (1.20%), and Geode Capital Management (1.02%).
Barclays Keeps Equal-Weight Rating on Stem and Increases Price Target to $18
Real-time Intelligence: Benzinga Pro offers fast and accurate stock market intelligence to help traders make informed decisions.
Exclusive Stories: The platform provides exclusive news stories generated by Benzinga reporters, enhancing the trading experience for its users.
Stem Scheduled to Announce Q4 Earnings on March 4
- Earnings Announcement Date: Stem is set to release its Q4 earnings report on March 4 after market close, with market participants keenly awaiting the results, which could impact stock performance.
- Earnings Expectations: Analysts have a consensus EPS estimate of -$1.96, indicating ongoing challenges in profitability that may affect investor confidence and stock valuation.
- Revenue Forecast: The consensus revenue estimate stands at $39.39 million, and any deviation from this figure could lead to stock price volatility, with lower revenues potentially dampening market sentiment.
- Historical Performance Insight: Historical earnings data for Stem will provide investors with critical insights into the company's financial health and market performance, aiding in future investment decisions.
Stem (STEM) Q4 2025 Earnings Call Transcript
Stempress Reports Q4 2025 Financial Results with Strong Revenue Growth
- Significant Revenue Growth: Stempress reported Q4 2025 revenue of $47.2 million, exceeding expectations by $7.81 million, with software, services, and edge hardware revenue reaching $46.5 million, reflecting a robust 62% year-over-year increase that underscores the company's strong market performance and growth potential.
- Improved Profit Margins: GAAP gross profit surged to $23.2 million from a loss of $2.5 million year-over-year, with GAAP gross margin rising to 49%, while non-GAAP gross margin increased from 36% to 45%, indicating significant advancements in cost control and profitability.
- Reduced Net Loss: The company reported a net loss of $16.0 million in Q4 2025, a substantial decrease from $51.1 million in the same quarter last year, reflecting positive changes in operational efficiency and financial health.
- Stable Annual Contract Revenue: The Contracted Annual Recurring Revenue (CARR) for FY25 stood at $67.2 million, down 4% from Q3 but up 4% year-over-year, demonstrating the company's ongoing commitment to maintaining long-term customer relationships and revenue stability.
Stem (STEM) Price Target Raised by 30.68% to $19.55
Price Target Update: The average one-year price target for Stem (NYSE:STEM) has been revised to $19.55 per share, reflecting a 30.68% increase from the previous estimate of $14.96, with current targets ranging from $17.17 to $24.15.
Fund Sentiment: There are 120 funds reporting positions in Stem, marking a 55.84% increase in ownership over the last quarter, with total shares owned by institutions rising by 32.64% to 2,087K shares.
Bullish Outlook: The put/call ratio for Stem is at 0.17, indicating a bullish sentiment among investors.
Shareholder Activity: Notable increases in share ownership have been reported by firms such as Marshall Wace, Bank of America, and Two Sigma Investments, with significant percentage increases in their portfolio allocations to Stem over the last quarter.
UBS Keeps Neutral Rating on Stem (STEM)
UBS Coverage and Price Forecast: UBS has maintained a Neutral recommendation for Stem (NYSE:STEM) as of October 31, 2025, with an average one-year price target of $14.96/share, indicating an 11.69% downside from its latest closing price of $16.94/share.
Projected Revenue and EPS: Stem's projected annual revenue is expected to reach $1,203 million, reflecting a significant increase of 629.32%, while the projected annual non-GAAP EPS is -0.17.
Fund Sentiment and Ownership: There has been a notable increase in institutional interest in Stem, with 113 funds reporting positions, a 653.33% increase in ownership over the last quarter, and total shares owned by institutions rising by 39,583.27% to 1,724K shares.
Shareholder Holdings: Key shareholders include Vanguard Total Stock Market Index Fund (2.90% ownership), Vanguard Extended Market Index Fund (1.48%), Bank of America (1.27%), Susquehanna International Group (1.20%), and Geode Capital Management (1.02%).
Barclays Keeps Equal-Weight Rating on Stem and Increases Price Target to $18
Real-time Intelligence: Benzinga Pro offers fast and accurate stock market intelligence to help traders make informed decisions.
Exclusive Stories: The platform provides exclusive news stories generated by Benzinga reporters, enhancing the trading experience for its users.
